Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wall Street Investor Relations (WallStreetIR) is a strategic investor relations and corporate communications firm that specializes in the micro-cap and small-cap sectors. The firm has a significant focus on the life sciences, biotechnology, and healthcare industries, providing tailored advisory services to emerging growth companies. Their core offerings include investor outreach, media relations, digital marketing, and the development of comprehensive investor presentation materials. WallStreetIR assists clients in navigating the capital markets by facilitating introductions to institutional investors, retail brokers, and financial analysts. By leveraging a broad network and deep industry expertise, the firm aims to enhance market visibility, liquidity, and shareholder value for its clients. Headquartered in New York, the company serves as a bridge between innovative healthcare firms and the global investment community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wall Street Investor Relations.